Di Biagio A - Search Results

1

Prevalence, awareness, treatment, and control rate of hypertension in HIV-infected patients: the HIV-HY study.

De Socio GV, Ricci E, Maggi P, Parruti G, Pucci G, Di Biagio A, Calza L, Orofino G, Carenzi L, Cecchini E, Madeddu G, Quirino T, Schillaci G; CISAI Study Group. De Socio GV, et al. Among authors: di biagio a. Am J Hypertens. 2014 Feb;27(2):222-8. doi: 10.1093/ajh/hpt182. Epub 2013 Sep 27. Am J Hypertens. 2014. PMID: 24077828

2

Predictive factors of hyperlipidemia in HIV-infected subjects receiving lopinavir/ritonavir.

Bongiovanni M, Bini T, Cicconi P, Landonio S, Meraviglia P, Testa L, Di Biagio A, Chiesa E, Tordato F, Biasi P, Adorni F, Monforte AD. Bongiovanni M, et al. Among authors: di biagio a. AIDS Res Hum Retroviruses. 2006 Feb;22(2):132-8. doi: 10.1089/aid.2006.22.132. AIDS Res Hum Retroviruses. 2006. PMID: 16478394

3

Lopinavir/ritonavir exposure in treatment-naive HIV-infected children following twice or once daily administration.

Rosso R, Di Biagio A, Dentone C, Gattinara GC, Martino AM, Viganò A, Merlo M, Giaquinto C, Rampon O, Bassetti M, Gatti G, Viscoli C. Rosso R, et al. Among authors: di biagio a. J Antimicrob Chemother. 2006 Jun;57(6):1168-71. doi: 10.1093/jac/dkl136. Epub 2006 Apr 10. J Antimicrob Chemother. 2006. PMID: 16606636 Clinical Trial.

4

Benign lymphoepithelial parotid lesions in vertically HIV-infected patients.

Rosso R, Pretolesi F, del Bono V, Buscaglia M, Ferrando S, Farinella ST, di Biagio A, Bassetti M, Derchi LE, Viscoli C. Rosso R, et al. Among authors: di biagio a. AIDS Patient Care STDS. 2006 Aug;20(8):536-41. doi: 10.1089/apc.2006.20.536. AIDS Patient Care STDS. 2006. PMID: 16893322

5

Therapeutical aspects and outcome of HIV/HCV coinfected patients treated with pegylated interferon plus ribavirin in an Italian cohort.

Righi E, Beltrame A, Bassetti M, Lindstrom V, Mazzarello G, Dentone C, Di Biagio A, Ratto S, Viscoli C. Righi E, et al. Among authors: di biagio a. Infection. 2008 Aug;36(4):358-61. doi: 10.1007/s15010-008-7319-5. Epub 2008 Jul 19. Infection. 2008. PMID: 18642111

6

Predictability of sustained virological response to pegylated interferon alpha-2b Plus ribavirin therapy by week-8 viral response in HIV-positive patients with chronic hepatitis C virus infection.

Angeli E, Mainini A, Cargnel A, Uberti-Foppa C, Orani A, Carbone R, Andreoni M, Schiavini M, Giorgi R, Rizzardini G, Gubertini G; ICoS-2 Group. Angeli E, et al. Curr HIV Res. 2009 Jul;7(4):447-55. doi: 10.2174/157016209788680507. Curr HIV Res. 2009. PMID: 19601782 Clinical Trial.

7

Rules-based HIV-1 genotypic resistance interpretation systems predict 8 week and 24 week virological antiretroviral treatment outcome and benefit from drug potency weighting.

Zazzi M, Prosperi M, Vicenti I, Di Giambenedetto S, Callegaro A, Bruzzone B, Baldanti F, Gonnelli A, Boeri E, Paolini E, Rusconi S, Giacometti A, Maggiolo F, Menzo S, De Luca A; ARCA Collaborative Group. Zazzi M, et al. J Antimicrob Chemother. 2009 Sep;64(3):616-24. doi: 10.1093/jac/dkp252. Epub 2009 Jul 19. J Antimicrob Chemother. 2009. PMID: 19620134 Free article.

8

Low rate of virological failure and maintenance of susceptibility to HIV-1 protease inhibitors with first-line lopinavir/ritonavir-based antiretroviral treatment in clinical practice.

Prosperi MC, Zazzi M, Punzi G, Monno L, Colao G, Corsi P, Di Giambenedetto S, Meini G, Ghisetti V, Bonora S, Pecorari M, Gismondo MR, Bagnarelli P, Carli T, De Luca A; ARCA Collaborative Group. Prosperi MC, et al. J Med Virol. 2010 Dec;82(12):1996-2003. doi: 10.1002/jmv.21927. J Med Virol. 2010. PMID: 20981785

9

Osteonecrosis in human immunodeficiency virus (HIV)-infected patients: a multicentric case-control study.

Mazzotta E, Agostinone A, Rosso R, Di Biagio A, De Socio GV, Cappelletti A, Zicolella R, Polilli E, Bonfanti P, Di Matteo L, Manzoli L, Parruti G. Mazzotta E, et al. Among authors: di matteo l, di biagio a. J Bone Miner Metab. 2011 May;29(3):383-8. doi: 10.1007/s00774-010-0245-5. Epub 2011 Jan 22. J Bone Miner Metab. 2011. PMID: 21258827

10

No pol mutation is associated independently with the lack of immune recovery in patients infected with HIV and failing antiretroviral therapy.

Gianotti N, Galli L, Zazzi M, Ghisetti V, Bonora S, Micheli V, Meraviglia P, Corsi P, Bruzzone B, Menzo S, Di Giambenedetto S, De Luca A, Filice G, Penco G, Castagna A; ARCA database initiative. Gianotti N, et al. J Med Virol. 2011 Mar;83(3):391-8. doi: 10.1002/jmv.21989. J Med Virol. 2011. PMID: 21264858

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

443 results

Search Page

Filters